Cochrane · systematic review · CD011039
Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome
Gonzalez-Garay, AG, Serralde-Zúñiga, AE, Velasco Hidalgo, L, et al. · Cochrane Database of Systematic Reviews · 2024 · Cochrane Library
Hepato-BiliaryAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
6
No studies
1
Included studies
NR
No studies 1 · 14.3%Ungraded 0 · 0%Very low 4 · 57.1%Low 2 · 28.6%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Transjugular intrahepatic portosystemic shunts compared with conventional treatment for hepatorenal syndrome
Population: adults with hepatorenal syndrome
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
All‐cause mortality Transjugular intrahepatic portosystemic shunts vs conventional treatment | RR 0.88 [0.55, 1.38] | 2 studies · 130 participants | Very low Downgraded: risk of bias, inconsistency |
Morbidity due to any cause Transjugular intrahepatic portosystemic shunts vs conventional treatment | RR 0.95 [0.77, 1.18] | 2 studies · 130 participants | Low Downgraded: risk of bias, imprecision |
Serious adverse events Transjugular intrahepatic portosystemic shunts vs conventional treatment | RR 1.6 [0.1, 24.59] | 2 studies · 130 participants | Very low Downgraded: risk of bias, imprecision, inconsistency |
Health‐related quality of life Transjugular intrahepatic portosystemic shunts vs conventional treatment | no estimate extracted | NR | No studies |
Participants who did not receive a liver transplant Transjugular intrahepatic portosystemic shunts vs conventional treatment | RR 1.03 [0.93, 1.14] | 2 studies · 130 participants | Very low Downgraded: risk of bias, imprecision |
Participants without improvement in kidney function Transjugular intrahepatic portosystemic shunts vs conventional treatment | RR 0.53 [0.27, 1.02] | 1 study · 70 participants | Low Downgraded: risk of bias, imprecision |
Length of hospitalisation measured in days Transjugular intrahepatic portosystemic shunts vs conventional treatment | no estimate extracted | 1 study · 60 participants | Very low Downgraded: risk of bias, imprecision |